Oncology

Filter

ESMO 2025 Abstract Highlights

5 Mins

December 2025

The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO)…

ESMO 2025 Abstract Highlights

The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO)…

Predisposition, Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Induced Nephritis

Immune checkpoint inhibitors (ICI) use can lead to an array of immune-related adverse events (irAE). Nephritis is considered to be…

ESMO 2024 Abstract Highlights

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) Congress 2024…

Swiss-PO: A Web Tool for Personalised Oncology – Upcoming Updates

Next-generation sequencing techniques enable rapid detection of mutations present in a patient’s tumour. The next step is to define…

Reduced Diversity of HLA Class I Alleles May Contribute to the Early Manifestation of Breast Cancer in Carriers of the BRCA1 Mutation

Most female carriers of germline BRCA1 mutations develop breast and/or ovarian cancer. However, the penetrance of BRCA1 pathogenic variants…

Precision Medicine-Based Platform to Guide the Treatment of EML4-ALK Lung Cancers and Other Non-Small Cell Lung Cancers

Lung cancer (LC) remains the top cause of cancer-associated mortality worldwide, with a 10-year overall survival rate of only 5%.1…

Programmed Death-Ligand 1 Expression and its Relation to EML4-ALK Gene Variants in Metastatic Lung Adenocarcinoma: A Single Centre Real-World Experience

Targeted therapy and immunotherapy have revolutionised the treatment of metastatic non-small cell lung cancer, particularly adenocarcinoma…

ESMO 2023 Abstract Highlights

FOR the first time, there is an alternative to chemotherapy for patients with advanced or metastatic urothelial carcinoma. The results of a…

Loading posts...

1 2 3 … 6 Next »